Published in World J Gastroenterol on August 21, 2006
Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control (2009) 1.52
IL6 genotypes and colon and rectal cancer. Cancer Causes Control (2007) 1.36
Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers. AIDS (2013) 1.34
Role of genetic & environment risk factors in the aetiology of colorectal cancer in Malaysia. Indian J Med Res (2014) 1.27
Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Mutat Res (2008) 1.18
Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.17
Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiol Biomarkers Prev (2011) 1.11
Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer (2008) 1.08
Relationship between the polymorphism of tumor necrosis factor-α-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. Eur J Hum Genet (2011) 0.96
Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer (2008) 0.92
Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis (2012) 0.89
Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals. Exp Ther Med (2012) 0.89
Association between the peroxisome proliferator-activated receptor gamma Pro12Ala variant and haplotype and pancreatic cancer in a high-risk cohort of smokers: a pilot study. Pancreas (2009) 0.88
Interleukin genes and associations with colon and rectal cancer risk and overall survival. Int J Cancer (2012) 0.88
Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results. Int J Colorectal Dis (2008) 0.86
Polymorphisms of ICAM-1 are associated with gastric cancer risk and prognosis. World J Gastroenterol (2012) 0.86
TNF-α-308 polymorphism and risk of digestive system cancers: a meta-analysis. World J Gastroenterol (2013) 0.84
Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies. Cancer Causes Control (2015) 0.84
The -174 G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan. J Clin Immunol (2009) 0.83
Tumor necrosis factor-a polymorphisms and colorectal cancer risk: a meta-analysis. PLoS One (2014) 0.83
The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer. DNA Cell Biol (2012) 0.83
PPARγ2 polymorphism and human health. PPAR Res (2009) 0.82
ICAM-1 +469 A/G polymorphism and cancer risk: a meta-analysis involving 9375 subjects. Int J Clin Exp Med (2014) 0.82
Biomarkers of Inflammation and Immune Function and Risk of Colorectal Cancer. Curr Colorectal Cancer Rep (2015) 0.82
Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (2013) 0.81
Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization. Sci Rep (2015) 0.80
Interleukin 8 and susceptibility to coronary artery disease: a population genetics perspective. J Clin Immunol (2008) 0.79
Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis. World J Gastroenterol (2010) 0.79
Dissecting the human plasma proteome and inflammatory response biomarkers. Proteomics (2009) 0.78
Association between six genetic polymorphisms and colorectal cancer: a meta-analysis. Genet Test Mol Biomarkers (2014) 0.78
Undefined familial colorectal cancer. World J Gastrointest Oncol (2009) 0.78
Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry. Carcinogenesis (2014) 0.77
Effect of Proliferator-Activated Receptor-γ Pro12Ala Polymorphism on Colorectal Cancer Risk: A Meta-Analysis. Med Sci Monit (2015) 0.77
Colorectal cancer severity and survival in correlation with tumour necrosis factor-alpha. Biotechnol Biotechnol Equip (2014) 0.77
Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study. Sci Rep (2015) 0.76
Risk modification of colorectal cancer susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol (2012) 0.76
Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk. Int J Clin Exp Med (2015) 0.75
Genetic polymorphisms of interleukin 1β gene and sporadic pancreatic neuroendocrine tumors susceptibility. World J Gastrointest Oncol (2016) 0.75
Association of PTEN gene polymorphisms with liver cancer risk. Int J Clin Exp Pathol (2015) 0.75
Peroxisome proliferator-activated receptor gamma (PPARG) rs1801282 C>G polymorphism is associated with cancer susceptibility in asians: an updated meta-analysis. Int J Clin Exp Med (2015) 0.75
Association of Polymorphisms in Intercellular Adhesion Molecule 1 (ICAM-1) Gene with Cancer Susceptibility: A Meta-Analysis of 14 Case-Control Studies. Med Sci Monit (2016) 0.75
Tumor necrosis factor-α (TNF-α)-308G/A promoter polymorphism in colorectal cancer in ethnic Kashmiri population - A case control study in a detailed perspective. Meta Gene (2016) 0.75
Polymorphisms in the intercellular adhesion molecule 1 gene and cancer risk: a meta-analysis. Int J Clin Exp Med (2015) 0.75
Polymorphism of the p38β gene in patients with colorectal cancer. Oncol Lett (2014) 0.75
Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy. Clin Cancer Res (2016) 0.75
Intercellular Adhesion Molecule-1 (ICAM-1) Polymorphisms and Cancer Risk: A Meta-Analysis. Iran J Public Health (2015) 0.75
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet (2000) 15.19
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest (1998) 6.76
Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med (1998) 5.16
Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer (2004) 4.43
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst (2002) 4.43
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst (2000) 3.57
Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem (1997) 3.55
Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem (1995) 3.13
Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet (1992) 3.12
Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem (2000) 3.03
Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell (1999) 2.71
Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax (2000) 2.49
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology (2003) 2.39
Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared. Trends Mol Med (2002) 2.24
Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res (2003) 2.18
Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res (2002) 2.09
Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med (2000) 2.08
Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol (2004) 1.96
Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol (2001) 1.83
Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells. Jpn J Cancer Res (1999) 1.63
Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull (2002) 1.53
Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res (2002) 1.50
Sex hormones as a cofactor in the pathogenesis of epidemic Kaposi's sarcoma. AIDS (1995) 1.43
A gender--dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol (2001) 1.29
Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease. Gastroenterology (1995) 1.18
Activation of PPARgamma increases PTEN expression in pancreatic cancer cells. Biochem Biophys Res Commun (2003) 1.12
Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster. Genomics (1994) 1.09
Association between K469E allele of intercellular adhesion molecule 1 gene and inflammatory bowel disease in a Japanese population. Gut (2003) 1.06
-174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res (2003) 1.05
A novel NlaIII polymorphism in the human IL-6 promoter. Eur J Immunogenet (1998) 1.05
Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol (1997) 1.02
Potential role for peroxisome proliferator activated receptor (PPAR) in preventing colon cancer. Gut (2003) 1.01
Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status. Clin Immunol (2001) 1.00
The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas. Carcinogenesis (2004) 0.99
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study. Cancer Lett (2003) 0.98
Molecular biology of colon polyps and colon cancer. Semin Surg Oncol (1996) 0.98
PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease. Trends Mol Med (2001) 0.96
Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro(12)Ala polymorphism in the PPARgamma gene. J Clin Endocrinol Metab (2002) 0.95
Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1. Life Sci (2002) 0.94
Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors. Int J Cancer (1994) 0.93
Over-representation of PPARgamma sequence variants in sporadic cases of glioblastoma multiforme: preliminary evidence for common low penetrance modifiers for brain tumour risk in the general population. J Med Genet (2000) 0.93
The -174 C/G locus affects in vitro/in vivo IL-6 production during aging. Exp Gerontol (2002) 0.92
The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients. Anticancer Res (2004) 0.92
Polymorphisms of tumour necrosis factors A and B in breast cancer. Eur J Immunogenet (2002) 0.91
Analysis of TNFB and TNFA NcoI RFLP in colorectal cancer. Mol Cells (1998) 0.89
Review article: cyclooxygenase--a target for colon cancer prevention. Aliment Pharmacol Ther (2000) 0.89
Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in endometriosis. Mol Hum Reprod (2003) 0.89
The regulation of ICAM-1 and LFA-1 interaction by autacoids and statins: a novel strategy for controlling inflammation and immune responses. J Pharmacol Sci (2003) 0.89
Molecular and genetic defects in colorectal tumorigenesis. Best Pract Res Clin Gastroenterol (2002) 0.81
Interaction of bacteria and bacterial toxins with intestinal epithelial cells. Curr Gastroenterol Rep (2001) 0.79
Polymorphism of tumor necrosis factor in esophageal, gastric or colorectal carcinoma. Hepatogastroenterology (2001) 0.77
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet (2008) 5.05
Septic shock; current pathogenetic concepts from a clinical perspective. Med Sci Monit (2005) 3.71
Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog (2011) 2.53
Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg (2006) 2.25
Rosacea: a clinicopathological approach. Dermatology (2004) 2.20
The impact of endograft type on inflammatory response after endovascular treatment of abdominal aortic aneurysm. J Vasc Surg (2013) 2.07
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol (2008) 1.85
Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: the way ahead. J Clin Microbiol (2005) 1.82
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet (2010) 1.72
Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications. Gynecol Oncol (2011) 1.60
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol (2006) 1.56
Percutaneous cholecystostomy without interval cholecystectomy as definitive treatment of acute cholecystitis in elderly and critically ill patients. South Med J (2008) 1.50
Hypoxemic reperfusion after 120 mins of intestinal ischemia attenuates the histopathologic and inflammatory response. Crit Care Med (2004) 1.50
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis (2015) 1.47
Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol (2004) 1.47
Differential effects of stent-graft fabrics on arterial stiffness in patients undergoing endovascular aneurysm repair. J Endovasc Ther (2014) 1.46
Liver tissue dissection: ultrasonic or RFA energy? World J Surg (2006) 1.43
Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature. Oral Oncol (2005) 1.43
A Malignant Gastrointestinal Stromal Tumor of the Gallbladder Immunoreactive for PDGFRA and Negative for CD 117 Antigen (c-KIT). HPB Surg (2011) 1.39
Mucoepidermoid carcinoma of the salivary glands. Review of the literature and clinicopathological analysis of 18 patients. Oral Oncol (2006) 1.39
Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer: A phase II study. Invest New Drugs (2005) 1.34
Pain in different methods of breast biopsy: emphasis on vacuum-assisted breast biopsy. Breast (2007) 1.31
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.27
Inflammatory pseudotumor associated with Mycobacterium tuberculosis infection. Int J Infect Dis (2008) 1.27
Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol (2011) 1.27
Clinical considerations and therapeutic strategy for sigmoid volvulus in the elderly: a study of 33 cases. World J Gastroenterol (2007) 1.27
Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas (2013) 1.26
TGF-beta signalling in colon carcinogenesis. Cancer Lett (2011) 1.26
Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24
Minimizing underestimation rate of microcalcifications excised via vacuum-assisted breast biopsy: a blind study. Breast Cancer Res Treat (2007) 1.18
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Hum Pathol (2011) 1.18
Bile duct injuries associated with laparoscopic and open cholecystectomy: an 11-year experience in one institute. Surg Today (2005) 1.18
Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol (2009) 1.17
Increasing diagnostic accuracy with a cell block preparation from thin-layer endometrial cytology: a feasibility study. Acta Cytol (2006) 1.14
Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium. Acta Neuropathol (2008) 1.13
The influence of platelet-rich plasma on angiogenesis during the early phase of tendon healing. Foot Ankle Int (2009) 1.13
BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort. Anticancer Res (2008) 1.12
Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer. Mod Pathol (2007) 1.09
Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol (2006) 1.09
Emergency liver resection for combined biliary and vascular injury following laparoscopic cholecystectomy: case report and review of the literature. South Med J (2007) 1.09
Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol (2008) 1.08
Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum (2005) 1.08
c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations. Urology (2004) 1.08
Pharmacokinetics of intravitreal bevacizumab (Avastin®) in rabbits. Clin Ophthalmol (2011) 1.08
Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX. Hum Pathol (2007) 1.08
Novel mutations and repeated findings of mutations in familial Alzheimer disease. Neurogenetics (2005) 1.07
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07
Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival. Hum Pathol (2008) 1.06
Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol (2008) 1.06
Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients. Cytokine (2007) 1.05
Detection of Mycobacterium avium subsp. paratuberculosis in retail cheeses from Greece and the Czech Republic. Appl Environ Microbiol (2005) 1.05
Coexistence of gastrointestinal stromal tumor (GIST) and colorectal adenocarcinoma: A case report. World J Surg Oncol (2007) 1.04
Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas. BMC Cancer (2006) 1.04
Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis (2011) 1.04
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
Laparoscopic gastric plication for the treatment of morbid obesity: a review. Minim Invasive Surg (2012) 1.03
Rectal carcinosarcoma: a case report and review of literature. World J Gastroenterol (2006) 1.03
Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. BJU Int (2005) 1.03
Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res (2010) 1.02
Postchemotherapy resection of a primary mature malignant retroperitoneal teratoma in an adult: report of a case. Surg Today (2005) 1.02
Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02
Two-trocar laparoscopic-assisted appendectomy versus conventional laparoscopic appendectomy in patients with acute appendicitis. J Laparoendosc Adv Surg Tech A (2006) 1.02
Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child-Pugh classification in predicting outcome. Surg Endosc (2009) 1.02
A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma. Pancreas (2012) 1.01
Cranioectodermal dysplasia: a probable ciliopathy. Am J Med Genet A (2009) 1.01
Analysis of PRNP gene codon 129 polymorphism in the Greek population. Eur J Epidemiol (2006) 1.01
Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis. Histopathology (2013) 1.01
FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk. Int J Colorectal Dis (2012) 1.01
Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival. Eur Urol (2002) 1.01
Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis. Med Oncol (2010) 1.01
Mutational analysis of BRAF in gallbladder carcinomas in association with K-ras and p53 mutations and microsatellite instability. Virchows Arch (2004) 1.00
γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer. Onco Targets Ther (2012) 1.00
mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells. Mol Cancer (2010) 1.00
E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res (2004) 1.00